|Articles|April 19, 2017

Certara Unveils New Tool for PK Data

Certara announced the launch of a new solution for preparing, analyzing and submitting pharmacokinectic data in Clinical Data Exchange Standards Consortium (CDISC) format.Read the full release here

Certara announced the launch of a new solution for preparing, analyzing and submitting pharmacokinectic data in Clinical Data Exchange Standards Consortium (CDISC) format.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Certara Unveils New Tool for PK Data

Newsletter

Related Content

After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies

Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor

Setting the Limits of Autonomy with Autonomous Agents for Clinical Research

Retention by Design: Operationalizing Patient-Centric Trials Without Increasing Site Burden

Streamlining Trial Design to Accelerate Data Delivery and Investor Confidence

Trending on Applied Clinical Trials Online

Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor

Future-Proofing Clinical Trial Supply Chains Against Tariff Risks

Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes

After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies

Labels That Withstand Liquid Nitrogen